Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837395 · ClinicalTrials.gov registry record
Inflammatory Mediators and microRNA Analysis in Premenstrual Asthma
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 24
- Enrollment target
NCT00837395: Clinical Trial study, sponsored by Ohio State University.
NCT00837395 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837395 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
A small number of women with asthma have an increase in asthma symptoms during the premenstrual or menstrual period. This study is being done to investigate the possible causes of this premenstrual increase in asthma symptoms and to help asthma care providers identify those patients who may suffer from this condition.
Primary Outcome
microRNA patterns in women with premenstrual asthma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-02 |
| Est. Completion | 2019-12 |
Why NCT00837395 stopped before completion
NCT00837395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00837395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00837395 about?
NCT00837395 is a clinical study titled "Inflammatory Mediators and microRNA Analysis in Premenstrual Asthma". A small number of women with asthma have an increase in asthma symptoms during the premenstrual or menstrual period. This study is being done to investigate the possible causes of this premenstrual increase in asthma symptoms and to help asthma care providers identify those patients who may suffer f...
What is the current status of trial NCT00837395?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2009-02. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT00837395?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia